Monte Rosa Therapeutics GLUE - Cadena de opciones | ADVFN

US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Monte Rosa Therapeutics Inc (GLUE)
Monte Rosa Therapeutics Inc (GLUE) Opciones

Monte Rosa Therapeutics Inc (GLUE)

6.67

-0.06

(-0.89%)

Al cierre: 18 Marzo 2:00PM

Delayed by 15 minutes

6.67

0.00

( 0.00% )

Fuera de horario: 3:41PM

Delayed by 15 minutes

GLUE Flujo de opciones

Calls

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
2.50	2.00	6.50	0.00	4.25	0.00	0.00 %	0	0	-
5.00	1.30	2.20	0.00	1.75	0.00	0.00 %	0	0	-
7.50	0.20	0.55	0.25	0.375	0.00	0.00 %	0	41	-

Su centro para precios en tiempo real, ideas y debates en vivo

Puts

Strike	Compra	Venta	Ultimo Precio	P. Medio	Variación	Variación %	Volume	Int Abierto	Último Operado
2.50	0.05	0.05	0.05	0.05	0.00	0.00 %	0	10	-
5.00	0.05	0.80	0.35	0.425	0.00	0.00 %	0	4	-
7.50	0.75	1.30	1.10	1.025	0.20	22.22 %	20	3	13:37:10

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
LSELeishen Energy Holding Company Ltd	US$ 13.08 (68.34%)	380.38k
ATERAterian Inc	US$ 2.8099 (33.17%)	1.39M
VRPXVirpax Pharmaceuticals Inc	US$ 0.1681 (29.31%)	15.1M
CRGXCARGO Therapeutics Inc	US$ 4.7492 (24.98%)	864.53k
XHLDTEN Holdings Inc	US$ 0.7023 (20.01%)	573k
KBSXFST Corporation	US$ 4.39 (-20.04%)	2.59M
FEAM5E Advanced Materials Inc	US$ 3.23 (-17.39%)	17.28k
CJETChijet Motor Company Inc	US$ 1.35 (-16.67%)	8.91k
CWDCaliberCos Inc	US$ 0.561 (-13.69%)	1.08k
WALDWaldencast PLC	US$ 2.87 (-13.16%)	63.78k
VRPXVirpax Pharmaceuticals Inc	US$ 0.1681 (29.31%)	15.1M
SYRSSyros Pharmaceuticals Inc	US$ 0.1195 (-6.64%)	4.8M
NVDANVIDIA Corporation	US$ 115.07 (-0.31%)	4.7M
AGMHAGM Group Holdings Inc	US$ 0.0672 (-3.45%)	4.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.6699 (2.68%)	3.52M

Monksdream

Monksdream 3 meses hace

corncakes0

corncakes0 4 meses hace

Woodpecker3

Woodpecker3 5 meses hace

$GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.

Woodpecker3

Woodpecker3 5 meses hace

$GLUE will soon be added to this list

https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

Woodpecker3

Woodpecker3 5 meses hace

$GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.

Woodpecker3

Woodpecker3 5 meses hace

$GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share

Monksdream

Monksdream 6 meses hace

Monksdream

Monksdream 6 meses hace

Monksdream

Monksdream 8 meses hace

Monksdream

Monksdream 8 meses hace

Monte Rosa Therapeutics

OAT 0 Pct 250568 CAC

Intra Cellular Therapies

Cherry Hill Mortgage Inv...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones